Latest Breaking News On - Apellis pharmaceuticals inc daily - Page 1 : comparemela.com

Stock Analysts Updated EPS Estimates for April 25th (APLS, BITF, LII, LSTA, MOH, NOW, NPI, NTB, STC, UHS)

Stock Analysts Updated EPS Estimates for April 25th (APLS, BITF, LII, LSTA, MOH, NOW, NPI, NTB, STC, UHS)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

William blairRaymond jamesNews ratings for apellis pharmaceuticals inc dailyApellis pharmaceuticalsApellis pharmaceuticals incStewart information servicesLennox internationalNeedham companyHealth servicesStock analystInformation servicesApellis pharmaceuticals inc daily

Equities Research Analysts Updated EPS Estimates for February 6th (APLS, BGNE, BRBR, CRMT, CTLT, DASH, DSCV, FN, INCY, JNJ)

Equities Research Analysts’ updated eps estimates for Tuesday, February 6th: Apellis Pharmaceuticals (NASDAQ:APLS) had its outperform rating reissued by analysts at Robert W. Baird. They currently have a $81.00 target price on the stock. BeiGene (NASDAQ:BGNE) had its overweight rating reissued by analysts at JPMorgan Chase & Co.. They currently have a $185.00 price target […]

United kingdomUnited statesWilliam blairRobertw bairdCantor fitzgeraldApellis pharmaceuticalsVertex pharmaceuticalsEquities research analystIe groupRoyal bankJpmorgan chase coNews ratings for apellis pharmaceuticals inc dailyMincon groupApellis pharmaceuticals incCanaccord genuity group incNeedham company

Apellis Pharmaceuticals (APLS) – Research Analysts Recent Ratings Updates

Apellis Pharmaceuticals (NASDAQ: APLS) has recently received a number of price target changes and ratings updates: 8/30/2023 – Apellis Pharmaceuticals had its “buy” rating reaffirmed by analysts at Needham & Company LLC. They now have a $60.00 price target on the stock. 8/29/2023 – Apellis Pharmaceuticals had its price target raised by analysts at Citigroup […]

United statesRobertw bairdAlec machielsPascal deschateletsStifel nicolausRaymond jamesAmerica coApellis pharmaceuticalsOppenheimer holdings incInstitutional investors weigh in on apellis pharmaceuticalsVanguard group incApellis pharmaceuticals incBlackrock incCitigroup incSecurities exchange commissionWells fargo company

Stock Analysts Downgrades for August 1st (APLS, BRO, CLAR, CNI, DMPZF, EL, EMN, FLO, FTI, HLF)

Stock Analysts’ downgrades for Tuesday, August 1st: Apellis Pharmaceuticals (NASDAQ:APLS) was downgraded by analysts at Bank of America Co. from a buy rating to a neutral rating. Bank of America Co. currently has $40.00 price target on the stock, down from their previous price target of $114.00. Brown & Brown (NYSE:BRO) was downgraded by analysts […]

United statesPiper sandlerStifel nicolausRobertw bairdWilliam blairRaymond jamesCitigroup incWells fargo companyReata pharmaceuticalsTopaz energyTelia companyBerenberg bankDeutsche bank aktiengesellschaftHovde groupValley national bancorpDomino pizza group